Antibodies directed against amyloidbeta peptide and methods using same

Details for Australian Patent Application No. 2005290250 (hide)

Owner Rinat Neuroscience Corp.

Inventors Grimm, Jan Markus; Ho, Wei-Hsien; Rosenthal, Arnon; Pons, Jaume

Agent Spruson & Ferguson

Pub. Number AU-A-2005290250

PCT Pub. Number WO2006/036291

Priority 60/653,197 14.02.05 US; 60/676,093 29.04.05 US; 60/592,494 30.07.04 US

Filing date 1 August 2005

Wipo publication date 6 April 2006

International Classifications

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

8 February 2007 PCT application entered the National Phase

  PCT publication WO2006/036291 Priority application(s): WO2006/036291

11 February 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005290253-Wax emulsion preservative compositions and method of manufacture

2005290240-Ocular implant made by a double extrusion process